HopeStage
Back to all studies
RecruitingNCT06835907

Baclofen for alcohol use disorder and anxiety symptoms

About this title

Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study

Read the official source —
Interventional studyAges 18–65BelgiumAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 28, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
58
Sponsor
Universitair Ziekenhuis Brussel
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Belgium
Age range
From 18 Years to 65 Years
Official registry ID
NCT06835907
Official title
Show the full official title

Investigating the Efficacy of Baclofen in Patients with Alcohol Use Disorder (AUD) and Comorbid Anxiety Symptoms

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Recruiting

Jette

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universitair Ziekenhuis Brussel.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies